Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes

ClinicalTrials.gov ID: NCT00322257

Public ClinicalTrials.gov record NCT00322257. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 3:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy

Study identification

NCT ID
NCT00322257
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
596 participants

Conditions and interventions

Interventions

  • inhaled human insulin Drug
  • insulin aspart Drug
  • insulin detemir Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2006
Primary completion
Apr 1, 2008
Completion
Apr 1, 2008
Last update posted
Sep 4, 2018

2006 – 2008

United States locations

U.S. sites
86
U.S. states
34
U.S. cities
81
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35294
Novo Nordisk Investigational Site Tuscaloosa Alabama 35406
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Encino California 91436
Novo Nordisk Investigational Site Escondido California 92025
Novo Nordisk Investigational Site Fresno California 93720
Novo Nordisk Investigational Site Inglewood California 90301
Novo Nordisk Investigational Site La Jolla California 92037
Novo Nordisk Investigational Site Mission Viejo California 92691
Novo Nordisk Investigational Site Poway California 92064
Novo Nordisk Investigational Site San Mateo California 94401
Novo Nordisk Investigational Site Santa Barbara California 93105
Novo Nordisk Investigational Site Tustin California 92780
Novo Nordisk Investigational Site Vista California 92084
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Aurora Colorado 80045
Novo Nordisk Investigational Site Colorado Springs Colorado 80909
Novo Nordisk Investigational Site New Britain Connecticut 06050
Novo Nordisk Investigational Site Norwalk Connecticut 06851
Novo Nordisk Investigational Site Waterbury Connecticut 06708
Novo Nordisk Investigational Site Boca Raton Florida 33433
Novo Nordisk Investigational Site Hollywood Florida 33021
Novo Nordisk Investigational Site Lake Mary Florida 32746
Novo Nordisk Investigational Site Melbourne Florida 32901
Novo Nordisk Investigational Site Merritt Island Florida 32953
Novo Nordisk Investigational Site Miami Florida 33136
Novo Nordisk Investigational Site West Palm Beach Florida 33401
Novo Nordisk Investigational Site Athens Georgia 30606
Novo Nordisk Investigational Site Atlanta Georgia 30318
Novo Nordisk Investigational Site Savannah Georgia 31406
Novo Nordisk Investigational Site Honolulu Hawaii 96813
Novo Nordisk Investigational Site Honolulu Hawaii 96814
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596
Novo Nordisk Investigational Site Chicago Illinois 60607
Novo Nordisk Investigational Site Peoria Illinois 61615
Novo Nordisk Investigational Site Springfield Illinois 62711
Novo Nordisk Investigational Site Lafayette Indiana 47904
Novo Nordisk Investigational Site New Albany Indiana 47150
Novo Nordisk Investigational Site Des Moines Iowa 50314
Novo Nordisk Investigational Site Shawnee Mission Kansas 66204
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Lexington Kentucky 40503
Novo Nordisk Investigational Site Baton Rouge Louisiana 70808
Novo Nordisk Investigational Site Scarborough Maine 04074
Novo Nordisk Investigational Site Hyattsville Maryland 20782
Novo Nordisk Investigational Site Springfield Massachusetts 01199
Novo Nordisk Investigational Site Waltham Massachusetts 02453
Novo Nordisk Investigational Site Bloomington Minnesota 55420
Novo Nordisk Investigational Site Duluth Minnesota 55805
Novo Nordisk Investigational Site Minneapolis Minnesota 55416-2699
Novo Nordisk Investigational Site Tupelo Mississippi 38801
Novo Nordisk Investigational Site Jefferson City Missouri 65109
Novo Nordisk Investigational Site Kansas City Missouri 64114
Novo Nordisk Investigational Site St Louis Missouri 63141
Novo Nordisk Investigational Site Butte Montana 59701
Novo Nordisk Investigational Site Omaha Nebraska 68114
Novo Nordisk Investigational Site Dover New Hampshire 03820
Novo Nordisk Investigational Site Hampton New Hampshire 03842
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648
Novo Nordisk Investigational Site Albany New York 12206
Novo Nordisk Investigational Site New Hyde Park New York 11042
Novo Nordisk Investigational Site Rochester New York 14642
Novo Nordisk Investigational Site Asheville North Carolina 28803
Novo Nordisk Investigational Site Greenville North Carolina 27834
Novo Nordisk Investigational Site Cincinnati Ohio 45267
Novo Nordisk Investigational Site Cleveland Ohio 44122
Novo Nordisk Investigational Site Dayton Ohio 45406
Novo Nordisk Investigational Site Kettering Ohio 45429
Novo Nordisk Investigational Site Mentor Ohio 44060
Novo Nordisk Investigational Site Medford Oregon 97504
Novo Nordisk Investigational Site Hershey Pennsylvania 17033
Novo Nordisk Investigational Site Norristown Pennsylvania 19401
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107
Novo Nordisk Investigational Site Chattanooga Tennessee 37404
Novo Nordisk Investigational Site Chattanooga Tennessee 37411
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75246
Novo Nordisk Investigational Site Dallas Texas 75390-8858
Novo Nordisk Investigational Site Midland Texas 79707
Novo Nordisk Investigational Site San Antonio Texas 78229
Novo Nordisk Investigational Site Ogden Utah 84403
Novo Nordisk Investigational Site Olympia Washington 98502
Novo Nordisk Investigational Site Renton Washington 98057
Novo Nordisk Investigational Site Spokane Washington 99208
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00322257, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2018 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00322257 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →